1. Home
  2. ONB vs CORT Comparison

ONB vs CORT Comparison

Compare ONB & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old National Bancorp

ONB

Old National Bancorp

N/A

Current Price

$25.74

Market Cap

10.2B

Sector

Finance

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$113.95

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONB
CORT
Founded
1834
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
9.7B
IPO Year
2012
2001

Fundamental Metrics

Financial Performance
Metric
ONB
CORT
Price
$25.74
$113.95
Analyst Decision
Buy
Buy
Analyst Count
12
5
Target Price
$27.25
$96.50
AVG Volume (30 Days)
2.9M
723.9K
Earning Date
04-22-2026
04-30-2026
Dividend Yield
2.46%
N/A
EPS Growth
6.55
N/A
EPS
0.59
0.09
Revenue
$125,616,000.00
$761,407,000.00
Revenue This Year
$27.93
$26.08
Revenue Next Year
$5.10
$26.98
P/E Ratio
$44.14
$1,240.22
Revenue Growth
6.07
12.79
52 Week Low
$19.39
$28.66
52 Week High
$27.36
$126.38

Technical Indicators

Market Signals
Indicator
ONB
CORT
Relative Strength Index (RSI) 44.93 53.75
Support Level $25.55 $77.73
Resistance Level $26.16 $124.30
Average True Range (ATR) 0.45 4.62
MACD -0.02 -1.64
Stochastic Oscillator 39.29 33.09

Price Performance

Historical Comparison
ONB
CORT

About ONB Old National Bancorp

Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: